Specify a stock or a cryptocurrency in the search bar to get a summary
Nautilus Biotechnology Inc
NAUTNautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. The company develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. It also offers proteome analysis system, a high-resolution optical imaging system for integrated fluidics and liquid handling sub-system. In addition, the company provides sample preparation, flow cells, multi-affinity probe reagents, and instrument buffers system to perform multi-cycle analysis runs. Nautilus Biotechnology, Inc. was incorporated in 2016 and is headquartered in Seattle, Washington. Address: 2701 Eastlake Avenue East, Seattle, WA, United States, 98102
Analytics
WallStreet Target Price
3.56 USDP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures NAUT
Dividend Analytics NAUT
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History NAUT
Stock Valuation NAUT
Financials NAUT
Results | 2019 | Dynamics |